Viet Nam Medicinal Materials JSC
VN:DVM
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Viet Nam Medicinal Materials JSC
Income Statement
Viet Nam Medicinal Materials JSC
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
52 967
|
57 686
|
58 597
|
56 548
|
50 076
|
47 544
|
47 700
|
0
|
0
|
|
| Revenue |
1 210 511
N/A
|
1 275 925
+5%
|
1 481 720
+16%
|
1 629 032
+10%
|
1 586 671
-3%
|
1 701 690
+7%
|
1 579 969
-7%
|
1 505 924
-5%
|
1 561 392
+4%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(1 049 873)
|
(1 103 411)
|
(1 323 480)
|
(1 478 354)
|
(1 451 669)
|
(1 570 377)
|
(1 439 372)
|
(1 359 671)
|
(1 405 588)
|
|
| Gross Profit |
160 638
N/A
|
172 514
+7%
|
158 240
-8%
|
150 679
-5%
|
135 002
-10%
|
131 313
-3%
|
140 598
+7%
|
146 253
+4%
|
155 803
+7%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(48 693)
|
(58 852)
|
(56 502)
|
(55 458)
|
(53 016)
|
(42 064)
|
(39 674)
|
(40 414)
|
(50 034)
|
|
| Selling, General & Administrative |
(43 340)
|
(53 640)
|
(51 647)
|
(51 873)
|
(49 959)
|
(39 356)
|
(36 255)
|
(36 692)
|
(46 345)
|
|
| Depreciation & Amortization |
(5 342)
|
(5 199)
|
(4 855)
|
(3 477)
|
(2 950)
|
(2 600)
|
(3 419)
|
(3 371)
|
(3 338)
|
|
| Other Operating Expenses |
(12)
|
(12)
|
0
|
(107)
|
(107)
|
(107)
|
0
|
(351)
|
(351)
|
|
| Operating Income |
111 945
N/A
|
113 662
+2%
|
101 738
-10%
|
95 221
-6%
|
81 986
-14%
|
89 249
+9%
|
100 923
+13%
|
105 839
+5%
|
105 769
0%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(48 991)
|
(52 670)
|
(52 744)
|
(50 574)
|
(44 601)
|
(42 520)
|
(43 108)
|
(42 282)
|
(43 283)
|
|
| Non-Reccuring Items |
0
|
0
|
(107)
|
0
|
0
|
0
|
(351)
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(13)
|
0
|
0
|
0
|
(2 575)
|
0
|
0
|
|
| Total Other Income |
183
|
(180)
|
623
|
712
|
842
|
794
|
513
|
(3 704)
|
(4 390)
|
|
| Pre-Tax Income |
63 135
N/A
|
60 812
-4%
|
49 496
-19%
|
45 359
-8%
|
38 228
-16%
|
47 524
+24%
|
55 401
+17%
|
59 853
+8%
|
58 096
-3%
|
|
| Net Income | ||||||||||
| Tax Provision |
(9 934)
|
(8 845)
|
(6 334)
|
(5 655)
|
(4 415)
|
(6 735)
|
(7 527)
|
(7 951)
|
(7 934)
|
|
| Income from Continuing Operations |
53 201
|
51 967
|
43 162
|
39 704
|
33 812
|
40 788
|
47 875
|
51 902
|
50 162
|
|
| Net Income (Common) |
53 201
N/A
|
51 967
-2%
|
43 162
-17%
|
39 704
-8%
|
33 812
-15%
|
40 788
+21%
|
47 875
+17%
|
51 902
+8%
|
50 162
-3%
|
|
| EPS (Diluted) |
1 492.3
N/A
|
1 457.68
-2%
|
917.21
-37%
|
928.08
+1%
|
790.37
-15%
|
952.72
+21%
|
1 017.36
+7%
|
1 102.93
+8%
|
1 065.96
-3%
|
|
